克里奥瓦特:肺癌冷激活的试点研究,与高级NSCLC的免疫疗法结合
Antoine Desilets1,2, Gabryella Pinheiro2, Wiam Belkaid2
1Department of Medicine, Division of Hematology-Oncology, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada.
JTO clinical and research reports
|December 3, 2024
概括
结合免疫检查点抑制剂 (ICI) 的冷激活,通过增加CD8+T细胞透,对非小细胞肺癌 (NSCLC) 显示出有前途. 然而,组合疗法没有显示出与历史ICI单疗数据相比显著的治疗益处.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是癌症死亡的主要原因.
- 免疫检查点抑制剂 (ICI) 在晚期NSCLC中改善了结果,但耐药性是一个重大挑战.
- 正在探索冷激活,一种冷解诱导细胞死亡的技术,以增强ICI的抗瘤反应.
研究的目的:
- 评估结合ICI单疗的冷激活在晚期NSCLC患者的安全性和有效性.
- 评估客观反应率 (ORR) 和生存结果.
- 为了研究冷激活对瘤免疫细胞透的影响.
主要方法:
- 一个单臂1期临床试验招募了先前未经治疗的晚期NSCLC和高PD-L1表达的患者.
- 患者接受了冷激活,然后在5天后接受ICI单疗.
- 免疫组织化学分析了治疗前和治疗后瘤活检中的CD8+T细胞透.
主要成果:
- 客观反应率为25% (8名患者有2个部分反应).
- 组合疗法是安全的,耐受性良好,没有3-4级不良事件.
- 免疫组织化学检查显示,在临床上受益的患者中,CD8+ T细胞透率增加.
结论:
- 结合 pembrolizumab 的冷激活在 NSCLC 患者中是安全的和可以容忍的.
- 与历史ICI单疗数据相比,没有明确证明治疗效益.
- 相对分析证实了在经历临床益处的患者中CD8+ T细胞的招募.
相关概念视频
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:30Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338